课题基金 / 基金详情

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT
HIV-1 感染者中洛匹那韦/利托那韦药代动力学的性别差异
批准号：
7606811
负责人：
Judith S. Currier
金额：
$0.55万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-02-21 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606811
关键词：
AreaComputer Retrieval of Information on Scientific Projects DatabaseDoseDrug KineticsFundingGrantInstitutionLopinavirLopinavir/RitonavirResearchResearch PersonnelResourcesSex CharacteristicsSourceTimeUnited States National Institutes of HealthWomanmen

项目摘要

项目成果

Judith S. Currier的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. SPECIFIC AIMS To compare the pharmacokinetic (PK) parameter, area under the concentration-time curve (AUC) of Lopinavir (LPV) between HIV-1-infected men and women currently receiving similar doses of Lopinavir/ritonavir (LPV/RTV).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
UCLA-CDU CFAR